Metabolic Abnormalities in Schizophrenia
Author Information
Author(s): De Hert M, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J
Primary Institution: University Psychiatric Center Katholieke Universiteit Leuven
Hypothesis
Metabolic abnormalities would already be present in first-episode patients, but their prevalence would increase with duration of illness.
Conclusion
Metabolic abnormalities are inherent to schizophrenia and increase with the duration of the illness, necessitating early screening.
Supporting Evidence
- Metabolic abnormalities were present in first-episode patients.
- The prevalence of diabetes increased from 3% in first-episode patients to 16.5% in chronic patients.
- Patients with schizophrenia have higher rates of metabolic syndrome compared to the general population.
- Screening for metabolic abnormalities is necessary from the onset of schizophrenia.
Takeaway
People with schizophrenia can have health problems like diabetes even when they first get sick, and these problems get worse the longer they are sick.
Methodology
A cross-sectional study assessing metabolic abnormalities in 415 patients with schizophrenia, divided into four groups based on the duration of illness.
Potential Biases
Potential bias due to the study being conducted at a single site and the unequal distribution of patients across age bands.
Limitations
The study is cross-sectional, conducted at a single site, and had unequal distribution of patients across age bands.
Participant Demographics
67.2% male, 99% white and Belgian natives, mean age 37.7 years.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website